Lazard Asset Management LLC Catalyst Pharmaceuticals, Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 79,025 shares of CPRX stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,025

Previous 22,881 245.37%

Holding current value

$1.74 Million

Previous $354,000 343.79%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.19 - $21.35 $852,827 - $1.2 Million	56,144 Added 245.37%	79,025 $1.57 Million
Q2 2024 Aug 14, 2024	SELL	$14.68 - $16.92 $109,410 - $126,104	-7,453 Reduced 24.57%	22,881 $354,000
Q1 2024 May 14, 2024	BUY	$13.18 - $17.11 $107,192 - $139,155	8,133 Added 36.63%	30,334 $482,000
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $13,276 - $19,485	1,127 Added 5.35%	22,201 $373,000
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $35,981 - $46,231	3,078 Added 17.1%	21,074 $246,000
Q2 2023 Aug 14, 2023	SELL	$11.5 - $18.08 $59,593 - $93,690	-5,182 Reduced 22.36%	17,996 $241,000
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $243,493 - $357,429	-16,980 Reduced 42.28%	23,178 $384,000
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $208,642 - $332,124	17,032 Added 73.65%	40,158 $746,000
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $2,951 - $6,487	418 Added 1.84%	23,126 $296,000
Q2 2022 Aug 09, 2022	SELL	$6.23 - $8.57 $296,342 - $407,649	-47,567 Reduced 67.69%	22,708 $159,000
Q1 2022 May 13, 2022	BUY	$5.31 - $8.31 $334,004 - $522,707	62,901 Added 853.01%	70,275 $582,000
Q4 2021 Feb 09, 2022	SELL	$5.21 - $7.45 $7,507 - $10,735	-1,441 Reduced 16.35%	7,374 $49,000
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $42,752 - $53,242	8,815 New	8,815 $46,000
Q2 2021 Aug 12, 2021	SELL	$4.29 - $6.05 $92,591 - $130,577	-21,583 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$3.45 - $4.69 $74,461 - $101,224	21,583 New	21,583 $99,000
Q4 2020 Feb 11, 2021	SELL	$2.97 - $3.83 $53,938 - $69,556	-18,161 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$2.97 - $5.08 $20,169 - $34,498	6,791 Added 59.73%	18,161 $53,000
Q2 2020 Aug 13, 2020	SELL	$3.48 - $5.05 $4,732 - $6,868	-1,360 Reduced 10.68%	11,370 $52,000
Q1 2020 May 14, 2020	BUY	$2.61 - $5.21 $23,385 - $46,681	8,960 Added 237.67%	12,730 $49,000
Q4 2019 Feb 13, 2020	BUY	$3.67 - $5.7 $13,835 - $21,489	3,770 New	3,770 $14,000

Others Institutions Holding CPRX

# of Institutions

327

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.27B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Catalyst Pharmaceuticals, Inc. Transaction History